Where postmenopausal hormone therapy stands today Amos Pines Mini Review 01 October 2009 Pages: 227 - 231
Hormones, hormonal agents, and neuropeptides involved in the neuroendocrine regulation of sleep in humans Grigorios KotronoulasAntonios StamatakisFotini Stylianopoulou Review 01 October 2009 Pages: 232 - 248
The ‘rings of fire’ and thyroid cancer Leonidas H. DuntasChristos Doumas Mini Review 01 October 2009 Pages: 249 - 253
Antithyroid drugs used in the treatment of hyperthyroidism during breast feeding. An update and new perspectives Spyros KarrasThemistoklis TzotzasGerasimos E. Krassas Commentary 01 October 2009 Pages: 254 - 257
Extensive personal experience. Validation of prolactin levels in menstrual disorders and in prolactinomas Menelaos L. Batrinos Personal experience 01 October 2009 Pages: 258 - 266
The Pro12Ala polymorphism of the PPAR-γ gene is not associated with the polycystic ovary syndrome Nectaria XitaLeandros LazarosAgathocles Tsatsoulis Research paper 01 October 2009 Pages: 267 - 272
Comparison of two fixed activities of radioiodine therapy (370 vs. 555 MBq) in patients with Graves’ disease Andrew CollierSujoy GhoshJim McGarvie Research paper 01 October 2009 Pages: 273 - 278
Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children Mahin HashemipourRoya KelishadiParinaz Poursafa Research paper 01 October 2009 Pages: 279 - 285
Predictors of amputation in diabetics with foot ulcer: Single center experience in a large Turkish cohort Sena YesilBaris AkinciSevinc Eraslan Research paper 01 October 2009 Pages: 286 - 295
Thyroid volume, selenium levels and nutritional habits in a rural region in Albania John DoupisCharalambos StavrianosMaria Alevizaki Research paper 01 October 2009 Pages: 296 - 302
Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma Luis V. SyroBernd W. ScheithauerKalman Kovacs Case report 01 October 2009 Pages: 303 - 306